3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Warts
1
Virus Diseases
1
Skin Diseases, Viral
1
Skin Diseases, Infectious
1
Skin Diseases
1
Sexually Transmitted Diseases, Viral
1
Sexually Transmitted Diseases
1
Papillomavirus Infections
1
Condylomata Acuminata
1
Interventions
Gels
3
hecolin
1
berdazimer sodium
1
Vaccines, Synthetic
1
Vaccines
1
VP-102
1
Therapies, Investigational
1
Podophyllin
1
Papillomavirus Vaccines
1
Omiganan
1
Imiquimod
1
Human Papillomavirus Recombinant Vaccine nonavalent
1
Cryotherapy
1
Cantharidin
1
3-ingenyl angelate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Condylomata Acuminata
×
VP-102
×
Clear all
NCT03981822
2024-11-27
CARE-1
Verrica Pharmaceuticals Inc.
Phase 2
Completed
105 enrolled
24 charts